Morrison Foerster‘s China practice stands out for its expertise in technology deals, which covers online gaming, e-commerce, fintech and biotechnology, as well as the life sciences, healthcare, education and real estate sectors. Paul McKenzie, the managing partner of the Beijing and Shanghai offices, is ’recommended to any companies seeking M&A or corporate counsel in China‘, and in Shanghai, Chuan Sun focuses on TMT and life sciences transactions. Siyu Gao, Sarah Wang and Bingye Wu are the Mainland China associates to note. In Hong Kong, Thomas Chou co-heads the Asia private equity group; Marcia Ellis is global private equity practice co-chair; Maureen Ho is a private equity and real estate fund expert; and Vivian Yiu advises multinational corporations and Chinese enterprises on cross-border transactions. In April 2023, private equity fund specialist Rongjing Zhao joined the Mainland offices from Kirkland & Ellis International LLP, while former partner Ruomu Li departed for Cooley LLP in December 2022.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘The MoFo team has the ability and resources to drive large cross-border deals and provides legal solutions instead of just legal advice.’
‘Paul McKenzie is recommended to any companies seeking M&A or corporate counsel in China.'
‘Paul McKenzie has more than 25 years of experience in advising on complex deals and is a most reliable external counsel. Paul is super hands-on, responsive, and experienced in handling the most challenging deals.’

Key clients

Alibaba Group
Arm Limited
GLP
Jamieson Wellness
Softbank
Softbank Vision Fund
Silver Crest

Work highlights

Advised SoftBank Group Corp and SoftBank Vision Fund on their acquisition of a substantial interest in Arm China.
Advised Alibaba Group Holding Limited (AGH) on the renegotiation and amendment of various agreements between AGH and Ant Group Co., Ltd. (Ant), in relation to AGH’s acquisition of a 33% stake in Ant.
Advised Amperex Technology Limited on its RMB14bn joint ventures for mid-size battery cells and packs, and $1.5bn technology cross-licence arrangement.